170 related articles for article (PubMed ID: 20677266)
1. Intra-renal oxygenation in rat kidneys during water loading: effects of cyclooxygenase (COX) inhibition and nitric oxide (NO) donation.
Ji L; Li LP; Schnitzer T; Du H; Prasad PV
J Magn Reson Imaging; 2010 Aug; 32(2):383-7. PubMed ID: 20677266
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intra-renal oxygenation during water diuresis: a time-resolved study using BOLD MRI.
Tumkur SM; Vu AT; Li LP; Pierchala L; Prasad PV
Kidney Int; 2006 Jul; 70(1):139-43. PubMed ID: 16572109
[TBL] [Abstract][Full Text] [Related]
3. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
4. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
5. NO-donors (VII [1]): synthesis and cyclooxygenase inhibitory properties of N-and S-nitrooxypivaloyl-cysteine derivatives of naproxen -- a novel type of NO-NSAID.
Kartasasmita RE; Laufer S; Lehmann J
Arch Pharm (Weinheim); 2002 Aug; 335(8):363-6. PubMed ID: 12397619
[TBL] [Abstract][Full Text] [Related]
6. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.
White WB; Schnitzer TJ; Fleming R; Duquesroix B; Beekman M
Am J Cardiol; 2009 Sep; 104(6):840-5. PubMed ID: 19733721
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
Pini A; Viappiani S; Bolla M; Masini E; Bani D
J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
[TBL] [Abstract][Full Text] [Related]
8. Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD).
Geusens P
Expert Opin Biol Ther; 2009 May; 9(5):649-57. PubMed ID: 19392579
[TBL] [Abstract][Full Text] [Related]
9. Renal oxygenation changes during water loading as evaluated by BOLD MRI: effect of NOS inhibition.
Haque M; Franklin T; Prasad P
J Magn Reson Imaging; 2011 Apr; 33(4):898-901. PubMed ID: 21448955
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
[TBL] [Abstract][Full Text] [Related]
11. NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Zacharowski P; Breese E; Wood E; Del Soldato P; Warner T; Mitchell J
Eur J Pharmacol; 2005 Jan; 508(1-3):7-13. PubMed ID: 15680249
[TBL] [Abstract][Full Text] [Related]
12. Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β.
Cheleschi S; Pascarelli NA; Valacchi G; Di Capua A; Biava M; Belmonte G; Giordani A; Sticozzi C; Anzini M; Fioravanti A
Int Immunopharmacol; 2015 Sep; 28(1):794-801. PubMed ID: 26292179
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
14. NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor.
Ellis JL; Augustyniak ME; Cochran ED; Earl RA; Garvey DS; Gordon LJ; Janero DR; Khanapure SP; Letts LG; Melim TL; Murty MG; Schwalb DJ; Shumway MJ; Selig WM; Trocha AM; Young DV; Zemtseva IS
Inflammopharmacology; 2005; 12(5-6):521-34. PubMed ID: 16259719
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the anti-inflammatory properties of NCX 429, a dual-acting compound releasing nitric oxide and naproxen.
Amoruso A; Fresu LG; Dalli J; Miglietta D; Bardelli C; Federici Canova D; Perretti M; Brunelleschi S
Life Sci; 2015 Apr; 126():28-36. PubMed ID: 25711428
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2.
Miyataka M; Rich KA; Ingram M; Yamamoto T; Bing RJ
Hypertension; 2002 Mar; 39(3):785-9. PubMed ID: 11897764
[TBL] [Abstract][Full Text] [Related]
17. [Renal tolerance of selective inhibitors of cyclooxygenase type 2].
Deray G
Presse Med; 2001 Oct; 30(30):1507-12. PubMed ID: 11712212
[TBL] [Abstract][Full Text] [Related]
18. Effect of nitric oxide synthase inhibition on intrarenal oxygenation as evaluated by blood oxygenation level-dependent magnetic resonance imaging.
Li LP; Ji L; Santos E; Dunkle E; Pierchala L; Prasad P
Invest Radiol; 2009 Feb; 44(2):67-73. PubMed ID: 19034027
[TBL] [Abstract][Full Text] [Related]
19. Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat.
Muscará MN; McKnight W; Del Soldato P; Wallace JL
Life Sci; 1998; 62(15):PL235-40. PubMed ID: 9566780
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure effects of naproxcinod in hypertensive patients.
Townsend R; Bittar N; Rosen J; Smith W; Ramsay A; Chrysant SG; Weiss R; Pivodic A; Duquesroix B; Djian J
J Clin Hypertens (Greenwich); 2011 May; 13(5):376-84. PubMed ID: 21545399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
